Autoimmune Hemolytic Anemia with Anti Jka Specificity in a Patient Taking Aldomet

Authors:

Abstract
Autoimmune hemolytic anemia (hemoglobin 5.2 g, reticulocyte count 31.0 per cent) developed in a 53‐year‐old hypertensive woman who was taking Aldomet. Both the patient's serum and the eluate prepared from her red blood cells contained an antibody with anti‐Jka specificity. Rapid sustained improvement in the anemia occurred after cessation of Aldomet and a two week course of prednisone therapy. Eight months later, anti‐Jka was no longer detectable in the patient's serum and the direct antiglobulin test was nonreactive.